Placebo-controlled clinical trial to evaluate the efficacy and safety of hydroxychloroquine and azithromycin in relation to placebo in the negative viral load of participants with SARS-CoV2 flu syndrome and who do not have an indication for hospitalization : Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of hydroxychloroquine and azithromycin versus placebo in the negative viral load of participants with flu syndrome caused by SARS-CoV2 and who have no indication for hospitalization - NA : NA

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: SARS Cov2 virus infection;B97.2
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-04-2020, Last updated: 2023-06-05

ICTRP ID:

RBR-95yjmq

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004346467